FDA Recall Terminated

The Tina-quant lgA Gen.2 is an immunoturbidimetric assay. Anti-lgA antibodies react with antigen in the sample to form an antigen/antibody complex which is measured turbidimetrically.

Recall: Z-1979-2019 · Initiated June 3, 2019

Recall

Recall Number
Z-1979-2019
Event Number
83095
Firm
Roche Diagnostics Corporation
FEI Number
1823260
Product Code
CZP
Status
Terminated
Root Cause
Material/Component Contamination
Initiated
June 3, 2019
Terminated
August 28, 2020
Address
9115 Hague Rd, Indianapolis, IN, 46256-1025

Description

The Tina-quant lgA Gen.2 is an immunoturbidimetric assay. Anti-lgA antibodies react with antigen in the sample to form an antigen/antibody complex which is measured turbidimetrically.

Reason

Calibration failures with Std.E, Sens.E, or Dup.E error due to atypical reaction kinetics and quality control failures have occurred due to contamination of R1 reagent with R3 reagent.

Action

Urgent Medical Device Correction notification letters dated 6/3/19 were sent to customers.

Distribution

The products were distributed to the following US states: AL, IN, and KY.

Quantity

8 units